CircNFIX Acts as a miR-212-3p Sponge to Enhance the Malignant Progression of Non-Small Cell Lung Cancer by Up-Regulating ADAM10

References

• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.2149230207593
   PubMed Web of Science ®Google Scholar
• Skřičková J, Kadlec B, Venclíček O. [Non-small cell lung cancer]. Vnitr Lek. 2018;63(11):861–874. Czech.29303290
   PubMedGoogle Scholar
• Herbst RS, Morgensztern D, Boshoff C. The biology and management of non-small cell lung cancer. Nature. 2018;553(7689):446–454. doi:10.1038/nature2518329364287
   PubMed Web of Science ®Google Scholar
• Yang L, Ying S, Hu S, et al. EGFR TKIs impair lysosome-dependent degradation of SQSTM1 to compromise the effectiveness in lung cancer. Signal Transduct Target Ther. 2019;4(1):25. doi:10.1038/s41392-019-0059-4
   PubMed Web of Science ®Google Scholar
• Yuan M, Huang LL, Chen JH, et al. The emerging treatment landscape of targeted therapy in non-small-cell lung cancer. Signal Transduct Target Ther. 2019;4(1):61. doi:10.1038/s41392-019-0099-931871778
   PubMedGoogle Scholar
• Fischer JW, Leung AK. CircRNAs: a regulator of cellular stress. Crit Rev Biochem Mol Biol. 2017;52(2):220–233. doi:10.1080/10409238.2016.127688228095716
   PubMed Web of Science ®Google Scholar
• Kristensen LS, Hansen TB, Venø MT, et al. Circular RNAs in cancer: opportunities and challenges in the field. Oncogene. 2018;37(5):555–565. doi:10.1038/onc.2017.36128991235
   PubMed Web of Science ®Google Scholar
• Tan S, Sun D, Pu W, et al. Circular RNA F-circEA-2a derived from EML4-ALK fusion gene promotes cell migration and invasion in non-small cell lung cancer. Mol Cancer. 2018;17(1):138. doi:10.1186/s12943-018-0887-930236141
   PubMed Web of Science ®Google Scholar
• Jiang MM, Mai ZT, Wan SZ, et al. Microarray profiles reveal that circular RNA hsa_circ_0007385 functions as an oncogene in non-small cell lung cancer tumorigenesis. J Cancer Res Clin Oncol. 2018;144(4):667–674.29372377
   PubMed Web of Science ®Google Scholar
• Chen L, Nan A, Zhang N, et al. Circular RNA 100146 functions as an oncogene through direct binding to miR-361-3p and miR-615-5p in non-small cell lung cancer. Mol Cancer. 2019;18(1):13. doi:10.1186/s12943-019-0943-030665425
   PubMed Web of Science ®Google Scholar
• Zhang H, Wang X, Hu B, et al. Circular RNA ZFR accelerates non-small cell lung cancer progression by acting as a miR-101-3p sponge to enhance CUL4B expression. Artif Cells Nanomed Biotechnol. 2019;47(1):3410–3416. doi:10.1080/21691401.2019.165262331407591
   PubMed Web of Science ®Google Scholar
• Cui J, Li W, Liu G, et al. A novel circular RNA, hsa_circ_0043278, acts as a potential biomarker and promotes non-small cell lung cancer cell proliferation and migration by regulating miR-520f. Artif Cells Nanomed Biotechnol. 2019;47(1):810–821. doi:10.1080/21691401.2019.157584730873868
   PubMed Web of Science ®Google Scholar
• Ding C, Wu Z, You H, et al. CircNFIX promotes progression of glioma through regulating miR-378e/RPN2 axis. J Exp Clin Cancer Res. 2019;38(1):506. doi:10.1186/s13046-019-1483-631888753
   PubMed Web of Science ®Google Scholar
• Xu H, Zhang Y, Qi L, et al. NFIX circular RNA promotes glioma progression by regulating miR-34a-5p via notch signaling pathway. Front Mol Neurosci. 2018;11(225). doi:10.3389/fnmol.2018.00225.
   Web of Science ®Google Scholar
• Ding C, Yi X, Wu X, et al. Exosome-mediated transfer of circRNA CircNFIX enhances temozolomide resistance in glioma. Cancer Lett. 2020;479(1):1–12. doi:10.1016/j.canlet.2020.03.00232194140
   PubMedGoogle Scholar
• Babu N, Advani J, Solanki HS, et al. miRNA and proteomic dysregulation in non-small cell lung cancer in response to cigarette smoke. Microrna. 2018;7(1):38–53. doi:10.2174/221153660766618010316534329299995
   PubMedGoogle Scholar
• Leonetti A, Assaraf YG, Veltsista PD, et al. MicroRNAs as a drug resistance mechanism to targeted therapies in EGFR-mutated NSCLC: current implications and future directions. Drug Resist Updat. 2019;42(1):1–11. doi:10.1016/j.drup.2018.11.00230544036
   PubMedGoogle Scholar
• Chen Y, Min L, Ren C, et al. miRNA-148a serves as a prognostic factor and suppresses migration and invasion through Wnt1 in non-small cell lung cancer. PLoS One. 2017;12(2):e0171751. doi:10.1371/journal.pone.017175128199399
   PubMed Web of Science ®Google Scholar
• Huang W, Yan Y, Liu Y, et al. Exosomes with low miR-34c-3p expression promote invasion and migration of non-small cell lung cancer by upregulating integrin α2β1. Signal Transduct Target Ther. 2020;5(1):39. doi:10.1038/s41392-020-0133-y32317629
   PubMed Web of Science ®Google Scholar
• Qiu HB, Yang K, Yu HY, et al. Downregulation of long non-coding RNA XIST inhibits cell proliferation, migration, invasion and EMT by regulating miR-212-3p/CBLL1 axis in non-small cell lung cancer cells. Eur Rev Med Pharmacol Sci. 2019;23(19):8391–8402.31646569
   PubMed Web of Science ®Google Scholar
• Rivetti Di Val Cervo P, Lena AM, Nicoloso M, et al. p63-microRNA feedback in keratinocyte senescence. Proc Natl Acad Sci U S A. 2012;109(4):1133–1138. doi:10.1073/pnas.111225710922228303
   PubMed Web of Science ®Google Scholar
• Duma N, Santana-Davila R, Molina JR. Non-small cell lung cancer: epidemiology, screening, diagnosis, and treatment. Mayo Clin Proc. 2019;94(8):1623–1640. doi:10.1016/j.mayocp.2019.01.01331378236
   PubMed Web of Science ®Google Scholar
• Vo JN, Cieslik M, Zhang Y, et al. The landscape of circular RNA in cancer. Cell. 2019;176(4):869–881.e813. doi:10.1016/j.cell.2018.12.02130735636
   PubMed Web of Science ®Google Scholar
• Zhang HD, Jiang LH, Sun DW, et al. CircRNA: a novel type of biomarker for cancer. Breast Cancer. 2018;25(1):1–7.28721656
   PubMed Web of Science ®Google Scholar
• Zhang JF, Wang P, Yan YJ, et al. IL‑33 enhances glioma cell migration and invasion by upregulation of MMP2 and MMP9 via the ST2-NF-κB pathway. Oncol Rep. 2017;38(4):2033–2042. doi:10.3892/or.2017.592628849217
   PubMed Web of Science ®Google Scholar
• Sun XF, Shao YB, Liu MG, et al. High-concentration glucose enhances invasion in invasive ductal breast carcinoma by promoting Glut1/MMP2/MMP9 axis expression. Oncol Lett. 2017;13(5):2989–2995. doi:10.3892/ol.2017.584328521406
   PubMed Web of Science ®Google Scholar
• Akram M. Mini-review on glycolysis and cancer. J Cancer Educ. 2013;28(3):454–457. doi:10.1007/s13187-013-0486-923728993
   PubMed Web of Science ®Google Scholar
• Jiao L, Zhang HL, Li DD, et al. Regulation of glycolytic metabolism by autophagy in liver cancer involves selective autophagic degradation of HK2 (hexokinase 2). Autophagy. 2018;14(4):671–684. doi:10.1080/15548627.2017.138180428980855
   PubMed Web of Science ®Google Scholar
• Verduci L, Strano S, Yarden Y, et al. The circRNA-microRNA code: emerging implications for cancer diagnosis and treatment. Mol Oncol. 2019;13(4):669–680. doi:10.1002/1878-0261.1246830719845
   PubMed Web of Science ®Google Scholar
• Zhang L, Zhang Y, Wang S, et al. MiR-212-3p suppresses high-grade serous ovarian cancer progression by directly targeting MAP3K3. Am J Transl Res. 2020;12(3):875–888.32269720
   PubMed Web of Science ®Google Scholar
• Wang D, Zheng J, Liu X, et al. Knockdown of USF1 inhibits the vasculogenic mimicry of glioma cells via stimulating SNHG16/miR-212-3p and linc00667/miR-429 axis. Mol Ther Nucleic Acids. 2019;14(465):465–482. doi:10.1016/j.omtn.2018.12.01730743215
   PubMedGoogle Scholar
• Oh JY, Kim EH, Lee YJ. Synergistic autophagy effect of miR-212-3p in zoledronic acid-treated in vitro and orthotopic in vivo models and in patient-derived osteosarcoma cells. Cancers (Basel). 2019;11(11):1812. doi:10.3390/cancers11111812
   PubMed Web of Science ®Google Scholar
• Dang Y, Liu T, Yan J, et al. Gastric cancer proliferation and invasion is reduced by macrocalyxin C via activation of the miR-212-3p/Sox6 pathway. Cell Signal. 2020;66:109430. doi:10.1016/j.cellsig.2019.10943031726103
   PubMed Web of Science ®Google Scholar
• Wu X, Chen H, Zhang G, et al. MiR-212-3p inhibits cell proliferation and promotes apoptosis by targeting nuclear factor IA in bladder cancer. J Biosci. 2019;44(4). doi:10.1007/s12038-019-9903-5.
   Web of Science ®Google Scholar
• Sépult C, Bellefroid M, Rocks N, et al. ADAM10 mediates malignant pleural mesothelioma invasiveness. Oncogene. 2019;38(18):3521–3534. doi:10.1038/s41388-018-0669-230651596
   PubMed Web of Science ®Google Scholar
• Walkiewicz K, Nowakowska-Zajdel E, Strzelczyk J, et al. Serum levels of ADAM10, ADAM12, ADAM17 AND ADAM28 in colorectal cancer patients. J Biol Regul Homeost Agents. 2017;31(4):929–934.29254295
   PubMed Web of Science ®Google Scholar
• Tsang JYS, Lee MA, Chan TH, et al. Proteolytic cleavage of amyloid precursor protein by ADAM10 mediates proliferation and migration in breast cancer. EBioMedicine. 2018;38(89):89–99. doi:10.1016/j.ebiom.2018.11.01230470613
   PubMedGoogle Scholar
• Smith TM, Tharakan A, Martin RK. Targeting ADAM10 in cancer and autoimmunity. Front Immunol. 2020;11(499). doi:10.3389/fimmu.2020.00499
   Web of Science ®Google Scholar
• Guo J, He L, Yuan P, et al. ADAM10 overexpression in human non-small cell lung cancer correlates with cell migration and invasion through the activation of the Notch1 signaling pathway. Oncol Rep. 2012;28(5):1709–1718.22940701
   PubMed Web of Science ®Google Scholar
• Yoneyama T, Gorry M, Sobo-Vujanovic A, et al. ADAM10 sheddase activity is a potential lung-cancer biomarker. J Cancer. 2018;9(14):2559–2570. doi:10.7150/jca.2460130026855
   PubMed Web of Science ®Google Scholar
• Meng H, Huang Q, Zhang X, et al. MiR-449a regulates the cell migration and invasion of human non-small cell lung carcinoma by targeting ADAM10. Onco Targets Ther. 2019;12(3829):3829–3838. doi:10.2147/OTT.S19028231190882
   PubMedGoogle Scholar